Epitopix

Epitopix is a veterinary biologics company specializing in the development and manufacture of innovative vaccines for livestock and poultry. The company is best known for its proprietary Siderophore Receptor and Porin (SRP) technology, which targets highly conserved proteins on the surface of gram-negative bacteria to provide broad-spectrum protection. Their product portfolio includes USDA-licensed vaccines for Salmonella, E. coli, and Klebsiella, primarily serving the poultry, cattle, and swine industries. Since its acquisition by Vaxxinova in 2018, Epitopix continues to operate as a key research and production hub for advanced animal health solutions. The company's approach focuses on reducing the impact of bacterial diseases and supporting antibiotic stewardship in food animal production.